Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Fusion oncogenes in tumor development.

¹Lundberg Laboratory for Cancer Research, Department of Pathology, Göteborg University, Sahlgrenska University Hospital, SE-41345 Göteborg, Sweden. pierre.aman@llcr.med.gu.se

Seminars in Cancer Biology

|April 14, 2005

Summary

Fusion oncogenes, often found in rare cancers, arise from DNA double-strand breaks. Their tumor-specific activity depends on gene location, DNA repair, and the resulting oncoprotein

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

FET fusion oncoproteins enrich SWI/SNF complex subtypes and interaction partners.

Cellular & molecular biology letters·2025

Same author

Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid Liposarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024

Same author

Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development.

Journal of translational medicine·2024

Same author

Identification of genomic binding sites and direct target genes for the transcription factor DDIT3/CHOP.

Experimental cell research·2022

Same author

Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma.

Oncogenesis·2022

Same author

Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo.

Biomedicines·2022

Area of Science:

Oncology
Genetics
Molecular Biology

Background:

Fusion oncogenes are predominantly identified in rare cancer types and specific tumor subtypes.
Some fusion oncogenes are prevalent in healthy individuals, indicating they do not invariably drive tumor formation.
The formation of fusion oncogenes is linked to clustered DNA double-strand breaks.

Purpose of the Study:

To explore the factors influencing the formation and tumor-specific activity of fusion oncogenes.
To understand the biological mechanisms underlying oncogenic fusion gene generation and their role in cancer development.

Main Methods:

Analysis of genetic and molecular factors contributing to fusion oncogene formation.
Review of existing literature on fusion oncogene prevalence and characteristics.
Investigation of chromatin organization and DNA repair mechanisms in relation to gene fusions.

Main Results:

The risk of fusion oncogene formation increases with clustered DNA double-strand breaks.
Cell-type-specific chromatin organization influences the likelihood of specific gene fusions.
Transcriptional orientation, intron characteristics, and reading frame splicing are identified as risk factors.
The biological activity of the resulting oncoprotein is critical for tumor penetrance and specificity.

Conclusions:

Tumor specificity of fusion oncogenes is largely determined by the biological activity of the oncoprotein within specific target cells.
Multiple genetic and cellular factors contribute to the oncogenic potential and tissue specificity of fusion genes.

Related Experiment Videos